IVF invobioscience.com Company Net Income

The in vivo embryo incubation systems market is growing steadily, expanding the clinic network. On GURU.Markets, the cash profit of INVO Fertility Inc (IVF) visualizes this trend, where -0.01 describes the current status of the metric. Success is based on the unique INVOcell brand, however, risks are associated with changes in IVF insurance and a potential drop in demand due to the high cost of procedures.

IVF INVO Bioscience Net Income (04/29/2025 - 10/31/2026)

Financial and market metric breakdowns for INVO Fertility (IVF)

- market value and analyst target forecast:
Stock Price INVO Fertility Corp|IVF - Price Target Chart
- market capitalization data:
Market Value INVO Fertility Corp|IVF - Enterprise Value
- book capitalization indicators:
Net Assets per Share INVO Fertility|IVF - Company Net Assets|Market Capitalization to Net Assets invobioscience.com|IVF - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital INVO Fertility Inc|IVF - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio INVO Bioscience|IVF - Company Total Debt|Debt to Net Assets Ratio INVO Fertility Corp|IVF - Company Long-Term Debt|Company Current Liabilities INVO Fertility|Immediate Liquidity invobioscience.com
- earnings and multiples data:
IVF - Net Profit
Summary company analysis:INVO Fertility Corp (IVF)

To separate fundamental stability from market noise, it is necessary to assess the net financial result, stripped of subjective adjustments and reflecting the business's actual ability to service obligations without leveraged capital. By analyzing the profit dynamics of INVO Fertility Inc. (IVF), an investor can see the efficiency of monetizing the niche expertise of embryologists, where high human capital costs ensure revenue stability for INVO Fertility Inc. within the reproductive technology sector.

Main competitors

Boston Scientific Corporation Inc. (BSX) - Net Profit|Company Net Income Edwards Lifesciences|Company Net Income RMD|Net Profit PODD|Net Financial Result Zimmer Biomet Holdings|CooperVision - Net Income|ALGN (Align Corp) - Profit After Tax|Globus Medical, Inc. - Net Profit|Company Net Income TransMedics Group Inc|ATEC: Net Profit|Company Profit AORT|Net Income ENOV|IART: Final Profit|Company Net Income Establishment Labs (ESTA)|Net Income betabionics.com BBNX|Net Profit IRMD (IRADIMED)|Embecta Corp (EMBC) - Company Net Income|Tandem Diabetes - Net Profit|AXGN (Axogen Surgical) - Company Profit|SIBN: Net Profit|OFIX - Net Financial Result|BVS (Bioventus) - Net Profit|Net Income OrthoPediatrics Inc. (KIDS)|Net Profit TMCI|Net Profit Strata Medical (SRTA)|Company Net Income Carlsmed Inc CARL|rxsight.com - Company Net Income|CLPT: Net Income|Final Profit STXS (Stereotaxis Inc)|STIM: Net Profit|Company Net Income Sight Sciences Inc (SGHT)|Company Net Income Orchestra BioMed|ANIK - Annual Net Income|Net Income NSPR (InspireMD)|Net Profit zhjmedical.com (ZJYL)|Net Profit VANI (Vivani Medical)|Net Financial Result Xtant Medical Holdings, Inc. (XTNT)|NMTC - Company Net Income|Profit After Tax MODD|Myomo (MYO) - Company Net Income|Net Income Envoy Medical Inc.|VVOS (Vivos Therapeutics, Inc) - Net Profit|Company Net Income enVVeno Corp NVNO|Company Net Income Sintx Technologies (SINT)|tenonmed.com - Company Profit|Lifeward - Net Income|Profit After Payment of Taxes AMIX (Autonomix Medical Inc.)|Bone Biologics Corporation - Net Profit|Net Financial Result Axonics, Inc AXNX|BIOLASE, Inc. (BIOL) - Company Net Income|Company Profit DYNT|Net Income FNA|Company Net Income INVO